Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries
Overview
Authors
Affiliations
Context: The oocyte-secreted factors growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) play essential roles in follicle development and oocyte maturation, and aberrant regulation might contribute to the pathogenesis of polycystic ovary syndrome.
Objective: Are there measurable differences in concentrations of GDF9, BMP15, and the GDF9/BMP15 heterodimer in small antral follicle fluids from women with and without polycystic ovaries (PCO)?
Design And Setting: Follicle fluids (n = 356) were collected from 4- to 11-mm follicles in unstimulated ovaries of 87 women undergoing ovarian tissue cryopreservation for fertility preservation.
Patients: Twenty-seven women with PCO were identified and 60 women without PCO-like characteristics (non-PCO women) were matched according to age and follicle size.
Main Outcome Measures: Intrafollicular concentrations of GDF9, BMP15, GDF9/BMP15 heterodimer, anti-Mullerian hormone (AMH), inhibin-A and -B, total inhibin, activin-B and -AB, and follistatin were measured using enzyme-linked immunosorbent assays.
Results: The detectability of GDF9, BMP15, and the GDF9/BMP15 heterodimer were 100%, 94.4%, and 91.5%, respectively, and concentrations were significantly negatively correlated with increasing follicle size (P < 0.0001). GDF9 was significantly higher in women with PCO (PCO: 4230 ± 189 pg/mL [mean ± SEM], n = 188; non-PCO: 3498 ± 199 pg/mL, n = 168; P < 0.03), whereas BMP15 was lower in women with PCO (PCO: 431 ± 40 pg/mL, n = 125; non-PCO: 573 ± 55 pg/mL, n = 109; P = 0.10), leading to a significantly higher GDF9:BMP15 ratio in women with PCO (P < 0.01). Significant positive associations between BMP15 and AMH, activins, and inhibins in non-PCO women switched to negative associations in women with PCO.
Conclusions: Intrafollicular concentrations of GDF9 and BMP15 varied inversely in women with PCO reflecting an aberrant endocrine environment. An increased GDF9:BMP15 ratio may be a new biomarker for PCO.
Pan Y, Pan C, Zhang C J Ovarian Res. 2024; 17(1):237.
PMID: 39593094 PMC: 11590415. DOI: 10.1186/s13048-024-01551-9.
Thabet M, Abdelhafez M, Elshamy M, Albahlol I, Fayala E, Wageeh A Medicina (Kaunas). 2024; 60(8).
PMID: 39202581 PMC: 11356540. DOI: 10.3390/medicina60081300.
The Differentiation Fate of Granulosa Cells and the Regulatory Mechanism in Ovary.
Chen Y, Wang S, Zhang C Reprod Sci. 2024; .
PMID: 39192066 DOI: 10.1007/s43032-024-01682-w.
Zhang H, Chen S, Liu Y, Xie F, Wen H, Zhao S Vet Sci. 2024; 11(3).
PMID: 38535849 PMC: 10975710. DOI: 10.3390/vetsci11030115.
A rare germline BMP15 missense mutation causes hereditary ovarian immature teratoma in human.
Liu Y, Fan H, Kang X, Hao Y, Wang N, Zheng H Proc Natl Acad Sci U S A. 2024; 121(10):e2310409121.
PMID: 38427603 PMC: 10927523. DOI: 10.1073/pnas.2310409121.